XALKORI® (crizotinib) paediatric oral granule formulation for ALK-positive ALCL and IMT indications.

As country information may vary, please chose the country in which you are a patient for more information.

Copyright © 2024 Pfizer Inc. All rights reserved. PP-XLK-DEU-0717